HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217 | -99.4% | 210 | -99.3% | 0.00% | – |
| Q2 2023 | $35,781 | +127.1% | 30,845 | +195.6% | 0.00% | – |
| Q1 2023 | $15,754 | -42.7% | 10,433 | -5.1% | 0.00% | – |
| Q4 2022 | $27,488 | -98.8% | 10,995 | -98.0% | 0.00% | -100.0% |
| Q3 2022 | $2,351,000 | +10.4% | 557,092 | -27.0% | 0.00% | 0.0% |
| Q2 2022 | $2,130,000 | +147.4% | 763,515 | +407.0% | 0.00% | +100.0% |
| Q1 2022 | $861,000 | -78.6% | 150,607 | -65.8% | 0.00% | -50.0% |
| Q4 2021 | $4,023,000 | +91.7% | 440,684 | +124.5% | 0.00% | +100.0% |
| Q3 2021 | $2,099,000 | -54.5% | 196,281 | -34.0% | 0.00% | -66.7% |
| Q2 2021 | $4,614,000 | +15.1% | 297,277 | +20.2% | 0.00% | 0.0% |
| Q1 2021 | $4,007,000 | +796.4% | 247,239 | +1070.4% | 0.00% | – |
| Q4 2020 | $447,000 | +402.2% | 21,124 | +251.5% | 0.00% | – |
| Q3 2020 | $89,000 | -90.1% | 6,010 | -90.1% | 0.00% | -100.0% |
| Q2 2020 | $896,000 | +5.0% | 60,906 | -16.1% | 0.00% | 0.0% |
| Q1 2020 | $853,000 | -51.8% | 72,597 | -3.7% | 0.00% | 0.0% |
| Q4 2019 | $1,771,000 | -46.3% | 75,373 | -57.7% | 0.00% | -50.0% |
| Q3 2019 | $3,297,000 | -33.0% | 178,218 | -32.7% | 0.00% | -33.3% |
| Q2 2019 | $4,921,000 | +290.6% | 264,706 | +413.3% | 0.00% | +200.0% |
| Q1 2019 | $1,260,000 | -65.8% | 51,567 | -63.7% | 0.00% | -75.0% |
| Q4 2018 | $3,686,000 | +274.2% | 142,070 | +356.0% | 0.00% | +300.0% |
| Q3 2018 | $985,000 | -61.0% | 31,159 | -52.1% | 0.00% | -50.0% |
| Q2 2018 | $2,526,000 | -68.8% | 65,014 | -77.9% | 0.00% | -66.7% |
| Q1 2018 | $8,104,000 | -37.0% | 293,609 | -58.7% | 0.01% | -40.0% |
| Q4 2017 | $12,873,000 | +1.2% | 711,244 | -9.7% | 0.01% | -9.1% |
| Q3 2017 | $12,720,000 | -15.3% | 787,559 | -27.4% | 0.01% | -15.4% |
| Q2 2017 | $15,019,000 | +1810.8% | 1,084,528 | +1973.3% | 0.01% | +1200.0% |
| Q1 2017 | $786,000 | -73.1% | 52,310 | -76.6% | 0.00% | -66.7% |
| Q4 2016 | $2,922,000 | +501.2% | 223,183 | +691.7% | 0.00% | – |
| Q3 2016 | $486,000 | -30.1% | 28,190 | -26.7% | 0.00% | – |
| Q2 2016 | $695,000 | -11.8% | 38,447 | -7.4% | 0.00% | – |
| Q1 2016 | $788,000 | +36.8% | 41,511 | +92.3% | 0.00% | – |
| Q4 2015 | $576,000 | -90.9% | 21,586 | -91.7% | 0.00% | -100.0% |
| Q3 2015 | $6,337,000 | +5660.9% | 259,722 | +7234.7% | 0.01% | – |
| Q2 2015 | $110,000 | +103.7% | 3,541 | -5.4% | 0.00% | – |
| Q1 2015 | $54,000 | -15.6% | 3,743 | -41.3% | 0.00% | – |
| Q4 2014 | $64,000 | +814.3% | 6,374 | +653.4% | 0.00% | – |
| Q3 2014 | $7,000 | +133.3% | 846 | +312.7% | 0.00% | – |
| Q2 2014 | $3,000 | +200.0% | 205 | +197.1% | 0.00% | – |
| Q1 2014 | $1,000 | – | 69 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |